09:49 AM EST - Cipher Pharmaceuticals Inc. : Announced the Health Canada approval of OZANEX™ (ozenoxacin cream, 1%) a novel topical antibiotic indicated for the treatment of impetigo in patients aged 2 months and older. Cipher Pharmaceuticals Inc.
shares T.CPH are trading up $0.03 at $4.75.
